Antigen Recognition by Lymphocytes

淋巴细胞识别抗原

基本信息

  • 批准号:
    7187865
  • 负责人:
  • 金额:
    $ 128.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-12-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The specificities and numbers of lymphocytes in animals are tightly controlled to avoid autoimmunity and to avoid accumulation of lymphocytes generated during previous infections. This control can be achieved through the death of autoreactive lymphocytes as consequence of selection events. Similarly, many lymphocytes that are generated in response to infections die when the infectious agent disappears. The lymphocyte repertoire is also influenced by the ability of lymphocytes to alter their antigen receptor. For example, the antigen receptor expressed by some autoreactive lymphocytes can be modified either by deletion of the genes encoding the offending receptor, or by silencing the action of the autoreactive receptor. The numbers, specificities and activities of lymphocytes in animals are controlled, to avoid accumulation of the huge numbers of lymphocytes which are generated in each successive response to infection and to prevent autoimmunity. Several processes are used to achieve this control. Many of the lymphocytes which are generated in response to infections die when the infectious agent disappears. Some autoreactive lymphocytes die, others modify their receptors for antigen, either by deleting genes coding for the offending receptor, or by somehow silencing the action of the autoreactive receptor. Other autoreactive lymphocytes survive for a while as anergic cells and do not respond productively to antigen and have a shortened half life. The Projects in this Program will examine the ways in which lymphocytes are controlled, comparing the mechanisms used in different types of lymphocytes under different circumstances, with the goal of understanding how the immune system generates a useful but innocuous collection of antigen specific lymphocytes. The individual Projects will focus as follows: 1. On the role of bystander, non autoreactive receptors on B cells, and their ability to rescue cells bearing, in addition, autoreactive receptors from death. 2. On the generation and maintenance of anergic B cells, their specificities and the ability of infectious agents to allow these cells to escape anergy. 3. On the role of Bcl-2 related proteins in the death of activated T, and B cells. The Program has 4 Cores, all essential to the work on all Projects. The subjects of the Cores are: Flow Cytometry; Microscopy; Genetics and Administration. PROJECT 1: Mechanisms of B Cell Survival and Death (Pelanda, R.) PROJECT 1 DESCRIPTION (provided by applicant): Millions of B cells are generated daily that express autoreactive antibodies. Recent studies in mice indicate that newly generated immature B cells that react with autoantigens in the bone marrow undergo receptor editing and anergy, and that receptor editing contributes to a significant fraction of the peripheral protective antibody repertoire. These recent studies also suggest that clonal deletion, once thought the predominant mechanism of central tolerance, is probably a default pathway that is carried out when autoreactive B cells are unable to edit their receptors. It is intrinsic to this model that autoreactive B cells must survive for a certain amount of time in order to successfully edit their receptors. Differences in cell survival of autoreactive and non-autoreactive immature B cells ultimately control the selection of these cells and shape the peripheral B cell repertoire. Therefore, we propose that the window of survival of autoreactive immature B cells during which receptor editing takes place is absolutely essential for the development of a protective peripheral antibody repertoire. What physiologically controls the lifespan of immature B cells during receptor editing is not yet clear although likely involves the regulated activity of anti- and pro-apoptotic pathways. In addition to receptor editing, the generation of a specific, effective and innocuous B cell repertoire also relies on the signals that stop further Ig gene rearrangement upon expression of nonautoreactive BCRs and mediate immunoglobulin allelic/isotypic exclusion. Dysfunctions in these pathways may cause either excessive clonal deletion resulting in immunodeficiency or survival of autoreactive B cells resulting in autoimmunity. Available evidences indicate that the expression of non-autoreactive B cell antigen receptors generates tonic signals that are important for survival of non-autoreactive (primary and edited and possibly anergic) immature B cells as well as immunoglobulin allelic/isotypic exclusion. We propose that the NF-?B pathway, BAFF-R signaling and the Bcl-2 family properly translate B cell antigen receptor signaling to regulate cellular lifespan and immunoglobulin gene recombination. We have created mouse strains that generate either nonautoreactive or autoreactive immature B cells, and other strains that have abnormal levels of BCR and BAFF-R expression. Using these biological tools, we propose to determine how the NF-?B pathway and the Bcl-2 family regulate the lifespan of primary immature B cells, and what is the relative contribution of BCR and BAFF-R signaling to cell survival and establishment of Ig allelic/isotypic exclusion. This project will contribute to our understanding of what regulates the lifespan of developing B cells, in particular depending on whether the cells are autoreactive or not. Moreover, our findings will indicate possible mechanisms by which autoreactive B cells escape tolerance and eventually differentiate into autoantibody-forming cells.
描述(由申请人提供):严格控制动物淋巴细胞的特异性和数量,以避免自身免疫和避免先前感染中产生的淋巴细胞的积累。这种控制可以通过选择事件导致的自身反应性淋巴细胞死亡来实现。同样,当感染因子消失时,许多为应对感染而产生的淋巴细胞也会死亡。淋巴细胞改变其抗原受体的能力也影响淋巴细胞库。例如,一些自身反应性淋巴细胞表达的抗原受体可以通过删除编码冒犯受体的基因或通过沉默自身反应性受体的作用来修饰。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philippa C. Marrack其他文献

Philippa C. Marrack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philippa C. Marrack', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8311797
  • 财政年份:
    2011
  • 资助金额:
    $ 128.46万
  • 项目类别:
Functions of Bcl-2 Related Proteins in Activated T Cell Death
Bcl-2相关蛋白在活化T细胞死亡中的功能
  • 批准号:
    8311793
  • 财政年份:
    2011
  • 资助金额:
    $ 128.46万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7846521
  • 财政年份:
    2009
  • 资助金额:
    $ 128.46万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7694126
  • 财政年份:
    2008
  • 资助金额:
    $ 128.46万
  • 项目类别:
Functions of Bcl-2 Related Proteins in Activated T Cell Death
Bcl-2相关蛋白在活化T细胞死亡中的功能
  • 批准号:
    7663282
  • 财政年份:
    2008
  • 资助金额:
    $ 128.46万
  • 项目类别:
Administrative
行政的
  • 批准号:
    7188255
  • 财政年份:
    2007
  • 资助金额:
    $ 128.46万
  • 项目类别:
Functions of Bcl-2 Related Proteins in Activated T Cell Death
Bcl-2相关蛋白在活化T细胞死亡中的功能
  • 批准号:
    7188251
  • 财政年份:
    2006
  • 资助金额:
    $ 128.46万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7092608
  • 财政年份:
    2004
  • 资助金额:
    $ 128.46万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7227149
  • 财政年份:
    2004
  • 资助金额:
    $ 128.46万
  • 项目类别:
AMID in Apoptosis and p53-Mediated Downstream Effects
AMID 在细胞凋亡和 p53 介导的下游效应中的作用
  • 批准号:
    7908140
  • 财政年份:
    2004
  • 资助金额:
    $ 128.46万
  • 项目类别:

相似国自然基金

基于Recognition-VR 虚拟现实的“家庭-社区-医院三向联动”轻度认知障碍防治模式研究
  • 批准号:
    2021JJ60094
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Unrestricted antigen recognition by T lymphocytes
T 淋巴细胞不受限制的抗原识别
  • 批准号:
    DP170104386
  • 财政年份:
    2017
  • 资助金额:
    $ 128.46万
  • 项目类别:
    Discovery Projects
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo
体内淋巴细胞自身抗原识别的实时测量
  • 批准号:
    8191110
  • 财政年份:
    2011
  • 资助金额:
    $ 128.46万
  • 项目类别:
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo
体内淋巴细胞自身抗原识别的实时测量
  • 批准号:
    8263743
  • 财政年份:
    2011
  • 资助金额:
    $ 128.46万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7846521
  • 财政年份:
    2009
  • 资助金额:
    $ 128.46万
  • 项目类别:
The antigen recognition mechanism by dual receptors of cytotoxic T lymphocytes
细胞毒性T淋巴细胞双受体的抗原识别机制
  • 批准号:
    14570283
  • 财政年份:
    2002
  • 资助金额:
    $ 128.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7663286
  • 财政年份:
    1997
  • 资助金额:
    $ 128.46万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7929677
  • 财政年份:
    1997
  • 资助金额:
    $ 128.46万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    7483029
  • 财政年份:
    1997
  • 资助金额:
    $ 128.46万
  • 项目类别:
Antigen Recognition by Lymphocytes
淋巴细胞识别抗原
  • 批准号:
    8134395
  • 财政年份:
    1997
  • 资助金额:
    $ 128.46万
  • 项目类别:
ANTIGEN RECOGNITION BY LYMPHOCYTES
淋巴细胞对抗原的识别
  • 批准号:
    6627969
  • 财政年份:
    1985
  • 资助金额:
    $ 128.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了